Brief: Nordic Nanovector Q1 Comprehensive Loss Stable At NOK 92 Mln
May 26 (Reuters) - Nordic Nanovector ASA NANOV.OL :
* Q1 COMPREHENSIVE LOSS FOR Q1 AMOUNTED TO NOK 91.7 MILLION (LOSS OF NOK 91.6 MILLION)
* DUE TO COVID-19 SITUATION, THERE IS A NEED TO REVIEW TIMELINE FOR ENROLMENT OF PARADIGME,
WHICH
PREVIOUSLY WAS GUIDED FOR H2'2020
* CONTINUES TO TARGET READOUT OF TOP LINE DATA FROM PARADIGME IN 2021
Source text for Eikon: ID:nWkr37mH7J
Further company coverage: NANOV.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Thor Medical ASA
See all newsBrief: Thor Medical Enters Partnership Agreement With Minerva Imaging
Brief: Thor Medical Partners With Eckert & Ziegler
Brief: Thor Medical Completes Alphaone Production Facility At Herøya Industrial Park
Brief: Thor Medical Enters Multiyear Agreement With Node Pharma
Brief: Thor Medical H2 EBITDA Loss NOK 25.7 Mln